Response of Malignant Thymoma to Sorafenib.
Department of Oncology, University Hospital of Varese, Varese, Italy. Electronic address: elena.bolzacchini@hotmail.it.
Elena
E
Bolzacchini
Department of Oncology, University Hospital of Varese, Varese, Italy.
Claudio
C
Chini
Department of Oncology, University Hospital of Varese, Varese, Italy.
Graziella
G
Pinotti
D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D009536:Niacinamide / Q000031:analogs & derivatives* / Q000627:therapeutic use; D010671:Phenylurea Compounds / Q000627:therapeutic use*; D000077157:Sorafenib; D013945:Thymoma / Q000188:drug therapy* / Q000473:pathology; D013953:Thymus Neoplasms / Q000188:drug therapy* / Q000473:pathology; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D010671:Phenylurea Compounds; D009536:Niacinamide; D000077157:Sorafenib